Search results
Results from the WOW.Com Content Network
A Lyme disease vaccine has entered phase 3 clinical trials, per Pfizer. Here's how the vaccine works, when it might become available, and who it might benefit.
Anywhere from 30,000 up to 500,000 people develop Lyme disease from a tick bite each year, according to the C DC.For most, the infection is mild and easily treated with antibiotics.
A new Lyme disease vaccine is set to enter Phase 3 trials, representing a major step forward in preventing the tick-borne illness. Lyme disease vaccine may help people with long-term symptoms ...
Lyme disease is the most common disease spread by ticks in the Northern Hemisphere. [21] [8] Infections are most common in the spring and early summer. [4] Lyme disease was diagnosed as a separate condition for the first time in 1975 in Lyme, Connecticut. It was originally mistaken for juvenile rheumatoid arthritis. [22]
Pfizer, the maker of a COVID-19 vaccine, announced Monday it is starting a phase 3 clinical trial on its Lyme disease vaccine, known as VLA15. The study will include over 6,000 participants from ...
Lyme disease has become an insidious epidemic in the United States. Caused by bacteria transmitted by an infected tick bite, symptoms can include arthritis, cardiac and neurological problems if ...
1989 – First vaccine for Q fever [12] 1990 – First vaccine for hantavirus hemorrhagic fever with renal syndrome; 1991 – First vaccine for hepatitis A [13] 1998 – First vaccine for Lyme disease; 1998 – First vaccine for rotavirus [14]
He is also the principal investigator (PI) for a phase 3 Lyme disease vaccine study and is working on clinical trials for several other vaccines including COVID-19, and cytomegalovirus. [ 3 ]